All posts by medical

Covid-19 screening in IVF clinics: safety is the priority – Cambridge Network

My argument is that it is better to screen more for coronavirus and subsequently relax, than to create the potential for positive cases that will reduce staff availability and patient confidence, comments Dr Thanos Papathanasiou, Medical Director at Bourn Hall Clinic (pictured). IVF treatment requires close interactions with staff and a paper by Dr Papathanasiou has highlighted considerable inconsistencies in the official guidance for testing.

To help professionals working in fertility medicine to balance safety and cost, Dr Papathanasiou has compared in a paper the clinical guidance given by four societies: European Society of Human Reproduction and Embryology (ESHRE); American Society for Reproductive Medicine (ASRM); British Fertility Society (BFS) and Canadian Fertility and Andrology Society (CFAS). The paper has been accepted for publication by the Journal of Assisted Reproduction and Genetics (12 June 2020).

Dr Papathanasiou continues: Although there is guidance about when to test for COVID-19 it varies between scientific societies. This is because there is no relevant experience or research in the area of reproductive medicine; it is a new disease after all."

Assessment of risk is complicated, as it is known that some people carry the coronavirus and are infectious without showing any symptoms of the COVID-19 disease. Therefore, making the decision to treat based just on reporting of symptoms may not protect staff or other patients from infection. A test is needed to confirm good health, but not all clinics insist on this.

Dr Papathanasiou comments: The Human Fertility and Embryology Authority (HFEA), the regulatory body, does not instruct how intensively clinics should screen as its priority is for the clinic to have a plan of action with risk assessments and an audit trail.

As a result, it falls to individual clinics to decide how exactly they will set up their COVID-19 practices. Consequently, some will have stricter or looser protocols and this is causing confusion for patients.

IVF treatment requires a number of face-to-face interactions over a period of several weeks so Bourn Hall has introduced a COVID-19 screening process, including self-assessment and health questionnaires and COVID-19 testing for patients and staff, for its clinics in Cambridge, Norwich and Wickford.

Bourn Hall has also introduced new ways of working to reduce footfall in its clinics, enable social distancing where possible and strict use of appropriate personal protective equipment (PPE). A concern for the clinics and patients is that the implementation of these measures will increase the cost of each treatment cycle. At present, Bourn Hall is not passing on the increased costs to current patients other than an additional charge of 100 for each COVID-19 test.

Although a staged or triage approach based on self-assessment questionnaires and testing was recommend by all the societies, the type of questions and the timing of testing differs. For example, some include occupation as a risk factor and only one asks about local incidence of disease.

We will be making repeated assessments during treatment to confirm good health, Dr Papathanasiou continues. Even if this may mean treatment of an individual is cancelled as a precaution, safety is our priority. The good news is that this region has a relatively low number of incidents and we will be monitoring this closely within our decision-making.

Link:
Covid-19 screening in IVF clinics: safety is the priority - Cambridge Network

Woman gives birth to twin sons 10 years apart – Times Now

A Chinese woman gave birth to the twin brother of her son after 10 years. | Image: Hubei Maternal and Child Health Hospital 

Hubei: A woman has given birth to twin sons - 10 years apart. The woman gave to the twin brother of her son from an embryo that was frozen for 10 years.

Wang, from China, had been struggling to conceive a child. In 2009, she decided to try the in vitro fertilisation (IVF) treatment and doctors cultivated a "batch of embryos". They implanted one embryo into Wangin October of that year.

While Wang went on to give birth to baby 'Lulu' in June 2010, the doctors at Hubei Maternal and Child Health Hospital froze the rest of her eggs so that she could go through the process later.

About 10 years later, Wang (now 41) decided to have a second baby. When she returned to Director Xiao Mei, who helped her with her first pregnancy, the doctor recognised Wang immediately.

The hospital said that despite her age, Wang's pregnancy was "relatively smooth".

The woman welcomed her second son on June 16 after giving birth via cesarean. The baby who has been named Tongtong weighed 3.48 kilograms at the time of birth, exactly the same weight as that of his elder twin brother.

Human Fertilisation and Embryology Authority in the UK explains that there may be good quality embryos left over after the IVF treatment. Instead of discarding them, those embryos can be frozen to use in the future, in case the first treatment doesn't work. They can also be frozen to preserve fertility to try for a sibling at a later date.

"From a medical perspective, Lulu and Tongtong are twin brothers," Zheng Jie, a doctor from the fertility centre of the hospital, said.

"The same doctor did the test tube operation, the same doctor did the cesarean section operation, the two babies were the same batch of embryos, the same sex, the same weight, were also born in June," the hospital said, adding that the twins born10 years apart have so much in common that it's "extremely rare".

See original here:
Woman gives birth to twin sons 10 years apart - Times Now

How to cope with fertility treatment – EasternEye – Eastern Eye

FOOD WRITER SEETAL SAVLA DISCUSSES HER EMOTIONAL IVF JOURNEY

by MITA MISTRY

THE Covid-19 lockdown is having a detrimental effect on lives globally, but for many couples trying for a child it is a devastating time because fertility treatments have been indefinitely postponed and some feel they are running out of time.

As each day of lockdown progresses they feel like their chances of having a biological child are shrinking and its particularly terrifying for women who feel like their egg reserves are dwindling.

British Asian food writer Seetal Savla has been married for 11 years to her husband Neil and after suffering an early miscarriage from a biological pregnancy, has been trying for a baby for over four years. She has gone through three unsuccessful IVF cycles and a fourth has been interrupted due to the Covid-19 lockdown. The struggle has been made harder by an out dated cultural legacy that looks down on a woman who cant conceive.

Eastern Eye caught up with Savla to talk about her deeply emotional IVF journey, key advice for infertile couples and her future hopes.

Please tell us about your fertility journey?My husband and I suffered an early miscarriage from a natural pregnancy in 2016-2017. Until then, hed expressed a stronger desire to become a parent than I had, but this devastating loss was my catalyst to be proactive. It was a wakeup call for two reasons: wed been married for eight years and this was our sole pregnancy, plus it made me realise how much I wanted children. Amid all the pressure to procreate, Id suppressed my feelings, which had finally surfaced. We sought fertility treatment shortly afterwards, through the NHS and then private clinics. However, our fourth cycle has been postponed indefinitely due to Covid-19, which is frustrating.

How does it feel going through a cycle of IVF?It depends on the clinic, your protocol, the medications and your reaction to them, whether youre working, among others. During my first cycle, I felt overwhelmed. In hindsight, it was a breeze compared to the private clinic we chose for our second and third rounds. It was information and medication overload, which hit me so hard one day that I ended up in tears in the nurses office. On any given day, I flitted between anger that we had to undergo IVF, gratitude that we could afford it, shame, guilt and hatred towards my dysfunctional body, muted excitement about a positive outcome and fear of another failure.

How did it affect your daily life?The NHS cycle was so light that I continued to work and socialise. For the private rounds, it was a full-time job doing daily blood tests and scans, taking five to six different injections, plus pills and pessaries, at specific times throughout the day; it took over my life. By this time, I had changed jobs and did what I could around appointments until I was laid off for business reasons. Although being unemployed was a shock, the silver lining was that I had the headspace and time to fully focus on my relentless IVF schedule.

What is the hardest part of dealing with IVF/infertility?Undergoing IVF is like being on a never-ending rollercoaster ride: you are up and down emotionally. Each cycle is testing in different ways, with the toughest challenges being recovering from the heartbreak of yet another failed round and trying to remain hopeful when that final phone call only ever brings bad news. It hurts even more when the treatment overshadows your special occasions, such as our 10th anniversary, which was spent in blustery Brighton instead of beautiful Bali.

How did your family and friends help?We told our immediate families and close friends from the outset, all of whom were supportive. That said, we didnt divulge how traumatic the experience was, so they were taken aback when they read my first blog post revealing what went on behind closed doors. Having my sister, best friend and mother-in-law accompany me during certain clinic visits was also comforting. Furthermore, discovering the TTC community (Trying To Conceive) via Instagram was a lifeline as they instantly understood my hopes, fears and heartache.

Did you get community support?Our extended families have been a great source of support. By checking in with us to see how were coping, rooting for us and sending heartfelt messages after unsuccessful cycles, theyve given us considerable strength to keep going when we were close to giving up. It can be extremely difficult to know what to say to someone when their pain is so raw, but some people are naturally empathic and their words have soothed me.

Did you seek any other professional help?I started therapy after our third cycle. I sometimes find it easier to talk to strangers about my struggles. Therapists only have the backstory you share; theyre not personally invested in you, so they wont try to fix your problems with platitudes or fertility success stories. You get a neutral perspective and dont feel guilty for constantly talking about yourself as youre paying them to listen. With family and friends, youre conscious that youre offloading on them, you dont want to worry them and they have their own issues.

What advice would you give someone going through IVF and infertility?I recommend starting with the HFEA website (Human Fertilisation and Embryology Authority), which offers plenty of information about fertility treatments, funding, egg, sperm or embryo donation and UK clinics. Speaking of clinics, dont feel obliged to stick to the same one its okay to move if your original choice no longer works. Similarly, shop around when buying meds as prices vary (supermarket pharmacies are often the cheapest). Also, injecting yourself wont be as bad as you imagine (unless youre prescribed intramuscular injections). Lastly, there are many online and offline support networks, so please dont suffer in silence.

In what ways could all those women going through IVF/infertility be better supported?A one-size-fits-all solution is impossible because were all different. For me, being advised to just relax or stay strong and be positive is irritating as these words fail to acknowledge my inner turmoil. Instead of platitudes or pity, something like, Im sorry, this is s**t and Im thinking of you works well. Ask how they are, just listen and dont advise.

What would you say are your hopes for the future?To have a happy and healthy baby. Its hard to make plans given the uncertainty around Covid-19, but a baby would be miraculous. While I admire the determination of those who wont quit until they achieve their goal, reaching double digits for cycles, we couldnt continue without an end date. Being on the IVF treadmill is physically, mentally, emotionally and financially draining. If success eludes us, we will explore alternatives, starting with anonymous donor eggs. However, we do not want infertility to define us and some of us are ready to call time sooner than others.

Visit http://www.savlafaire.com, Twitter, Facebook & Instagram: @SavlaFaire

Read this article:
How to cope with fertility treatment - EasternEye - Eastern Eye

What does an immunologist do? CareerExplorer

What is an Immunologist?

An immunologist is a specialized medical doctor trained in managing problems related to the immune system, such as allergies and autoimmune diseases. Doctors in other fields of medicine refer their patients to immunologists if they suspect their patients medical condition has to do with the immune system.

A smaller number of immunologists are strictly researchers with advanced degrees (either a master's or a doctorate) in immunology. Immunologists who conduct research, do so to increase our understanding of how the immune system works. They also conduct research to find out what happens when the immune system fails to work properly, as well as to develop better ways of diagnosing and providing treatment for many immunological conditions.

Immunology is defined as the study of an organism's defence/immune system, in both health and disease. There are many harmful organisms such as viruses, bacteria and parasites constantly trying to gain access into the body, and if successful, can lead to a number of serious diseases. Immunologists work in many different areas of biomedical research, as well as in healthcare, agriculture and environmental monitoring.

Immunologists from developed nations are working together with countries in the developing world to help prevent and treat major problems associated with global health/disease. These include vaccine preventable diseases, emerging infectious diseases, HIV/AIDS, malaria, sexually transmitted diseases, tuberculosis, cancer and other neglected infectious diseases.

Am immunologist's job and their role often depends on the type of organization they work for:

Immunologists employed by health services tend to be either qualified doctors specializing in the study of diseases (pathology) or the study of allergies. They can also be scientists with expertise in a clinical laboratory.

Immunologists employed in the pharmaceutical and bio-technical industry help develop new medical products and therapies. They generally work with other scientists to produce new products or improve existing ones.

Immunologists employed by universities work in virtually every life science department or division conducting research to increase our understanding of the immune system. They can also work as lecturers, teaching students about Immunology while still conducting their own research.

Immunologists employed within the veterinary sciences, as veterinary immunologists, research better ways of improving animal healthcare by preventing disease, and by providing treatment for those animals suffering from infections and other immunological conditions.

Many diseases are caused when the immune system behaves incorrectly. Research immunologists try to understand how and why the immune system malfunctions and causes disease. Such diseases can be broadly classified into the following three categories:

Immunodeficiency: occurs when parts of the immune system fail to respond adequately to a harmful foreign substance or organism.

Autoimmunity: occurs when the immune system attacks the very tissue it is meant to protect; due to failure of the immune system to recognize its own tissues.

Hypersensitivity: occurs when the immune system responds inappropriately (sometimes too intensely) to harmless compounds.

Immunologists have distinct personalities. They tend to be investigative individuals, which means theyre intellectual, introspective, and inquisitive. They are curious, methodical, rational, analytical, and logical. Some of them are also social, meaning theyre kind, generous, cooperative, patient, caring, helpful, empathetic, tactful, and friendly.

Does this sound like you? Take our free career test to find out if immunologist is one of your top career matches.

Immunologists in the medical field are responsible for diagnosing and treating human patients with immunological disorders. They spend most of their time either in the laboratory conducting research to develop new therapies or diagnostic techniques, or in clinics discussing patient treatment strategies. They work in hospitals, medical research facilities, or in their own private practice.

Research immunologists employed by universities work in life science departments or divisions conducting research. They can also work as lecturers, teaching students about Immunology while still conducting their own research.

Immunologists are also known as:Allergist Research Immunologist Allergy Physician Allergy and Immunology Specialist Allergist/Immunologist

Visit link:
What does an immunologist do? CareerExplorer

Immunology < Laboratory Medicine

Allergen Testing

The laboratory provides reference diagnostics for both IgE and IgG responses to the full complement of potential allergens, whether food, environmental, or other. State-of-the art methodologies are employed. Individualized 'panel' testing of allergens appropriate to specific geographic areas and/or patient populations can be requested by individual physicians and practices.

Optimized evaluation and followup of patients with immunoproliferative disorders, including plasma cell dyscrasias, is an area of interest to the clinical laboratory, including complete cryoglobulin evaluation. The laboratory also concentrates on providing maximally cost-effective testing for rheumatologic and other autoimmune conditions.

Visit link:
Immunology < Laboratory Medicine

Immunology Books – Goodreads

The deviation of man from the state in which he was originally placed by nature seems to have proved to him a prolific source of diseases. From the love of splendour, from the indulgences of luxury, and from his fondness for amusement he has familiarised himself with a great number of animals, which may not originally have been intended for his associates.

The wolf, disarmed of ferocity, is now pillowed in the lady's lap. The cat, the little tiger of our island, whose natural home is the forest, is equally domesticated and caressed. The cow, the hog, the sheep, and the horse, are all, for a variety of purposes, brought under his care and dominion. Edward Jenner, Vaccination Against Smallpox

See more here:
Immunology Books - Goodreads

Why some people have allergies from dust mites and others don’t – Fairfield Daily Republic

Household allergens are common, but the way they affect people differs.

For some, encountering dust mites leads to itchiness, a runny nose and sneezing, while others remain unaffected. New research examines why this is the case to treat causes of allergies and asthma, which can be aggravated by allergic reactions.

In a study recently published in the journal Science Immunology, La Jolla Institute for Immunology scientists have found part of the answer for why nonallergic people dont have a severe reaction to house dust mites. A previously unknown subset of T cells has been uncovered. Those T cells may restrict allergic immune reactions and asthma from ever developing in response to possible allergens, including house dust mites.

We discovered new immune cell subsets and new therapeutic opportunities, Grgory Seumois, instructor and director of LJIs Sequencing Core and co-leader of the new study, said in a press release. This new population of cells could be one, out of many unknown mechanisms, that explains why healthy people dont develop inflammation when they breathe in allergens.

LJI professor Pandurangan Vijayanand, senior author of the new study, added: The study highlights the power of unbiased single-cell genomics approaches to uncover novel biology.

Using a method thats part of the genomic revolution arsenal of tools, called single-cell RNA-seq (or single-cell transcriptomics), researchers saw precisely which genes and molecules specific T cells produce in response to house dust mite allergens. Cells from four groups of people were tested: healthy participants, participants who suffer from asthma and HDM allergy, people who suffer only from asthma and no HDM allergy, and people who only have an HDM allergy.

The examination indicated a subset of helper T cells, called interleukin-9 Th2 expressing HDM-reactive cells, is more widespread in the blood of people with HDM-allergic asthma compared with people who only have HDM allergies. More examinations showed IL9-TH2 cells could kill other cells and promote inflammation.

On the other hand, another subset of T cells was prominent in nonallergic participants. The subset showed an interferon response signature and was enriched for a gene that encodes a protein called TRAIL.

Researchers work indicates TRAIL could be important since it could lessen the triggering of helper T cells.

The findings could provide some insight as to why some people develop asthma and allergies and others dont.

Now if functional studies confirm this dampening effect, were curious if there is a way to boost the activation of these T cells or induce their proliferation in asthmatic or allergic populations, Seumois said. Can we act on those cells very early on, before asthma has developed?

Related

Continued here:
Why some people have allergies from dust mites and others don't - Fairfield Daily Republic

The whole lot You Needed to Know About Your Immune System – Editorials 360

The workings of the human immune system are fascinating and particularly vital through the coronavirus outbreak. Whereas the immune systems armamentarium of stem cells, helper T cells, cytotoxic T cells and different fighters is spectacular, so is the armamentarium {that a} virus makes use of to invade cells and make them factories to duplicate it.

A vivid and entertaining video, The Wonderful Immunology of our Viral Difficulty and Herd Immunity Revelations! describes the continued warfare between your immune system and an invading virus, reminiscent of COVID-19. It was not too long ago created by Ivor Cummins, a chemical engineer who runs the well being web site The Fats Emperor.1 Creon Levit, chief scientist of Planet Labs, was the visitor.

Levit, who has collaborated with prime immunologists, is an expert utilized physicist who beforehand served as an aerospace engineer at NASA for over 35 years.2 Planet Labs is a personal satellite tv for pc knowledge firm that operates over 300 imaging satellites within the Earths low orbit.3

In The Wonderful Immunology of our Viral Difficulty and Herd Immunity Revelations! Levit showcases in vivid charts and visuals the various intricacies and cell signalings that allow the immune system to battle viruses like COVID-19 in addition to how viruses like COVID-19 can battle again.

An particularly burning query that Levit and Cummins handle is that if and the way herd immunity will be achieved in opposition to COVID-19. They attain some shocking findings.

Its generally believed that the one individuals who could have grow to be resistant to COVID-19 are those that present antibodies when theyre examined, says Cummins, and a rustics herd immunity is commonly primarily based on the outcomes of such checks. For instance, if 7% or 8% of a inhabitants have antibodies, its assumed {that a} nation has solely that low p.c of herd immunity. This can be a false impression, say each males within the video.

The science suggests that folks could have a major quantity of de facto or efficient immunity with out exhibiting antibodies, they are saying. For instance, some individuals, known as denatured or barriered circumstances, could have been uncovered to the virus however, not like these round them, didnt grow to be in poor health. In keeping with Lev:4

due to these individualss both luck or their wholesome metabolisms, the virus will get blocked via mucous membranes and different types of issues and it by no means truly infects their cells due to this fact they dont seem to be even mounting an immune response and so they may get challenged once more and maybe contaminated.

However, some quantity of people that get uncovered do not get the illness, not a lot due to a traditional immune response as a result of it is simply blocked via their physique membranes and kind of nonspecific processes.

In keeping with Cummins, if such individuals get previous the virus they dont seem to be going to be a spreader except they get an enormous viral load that is a lot larger ought to the virus come alongside once more. These individuals will not be contributors to herd immunity per se however theyre much less prone to getting the illness, clarifies Levit.5

Different individuals could contribute to a areas herd immunity too, but are sometimes not detected via present antibody checks which might be administered. Amongst these individuals are these thought-about to have an innate or cleared standing, which suggests, based on Levit:6

that sure facets of your immune system, sure antibodies and sure different signaling processes can stop or clear a viral an infection regardless that you have by no means been uncovered to that specific virus earlier than regardless that you havent any immunological reminiscence.

Such generalized immune responses that may acknowledge and battle viruses which have by no means been encountered earlier than are seen all through the animal world, particularly in primitive animals and even in microbial life, says Levit.7

The one immune system theyve is a generic system that targets usually all micro organism or usually all viruses and so this isnt a factor the place youd have particular antibodies to a selected virus, however you may have signaling the place virally contaminated cells do sure issues. After which the immune system begins setting close by cells into kind of antiviral modes

some individuals handle to battle off the infections presumably utilizing their innate immune system with out essentially getting sick, and producing adaptive or acquired immune response they actually did have an immune battle. They are going to go on to be de facto herd immunity contributors to society however they will not present antibodies.

In keeping with the video, mammalian immune programs have developed to focus on particular viruses or households of viruses and are all primarily based on T cells lymphocytes produced or processed by the thymus gland.

If somebody is contaminated with a virus, their physique can mount a T cell response focusing on that specific virus and the contaminated cells, particularly after they have immunological reminiscence. Immunological reminiscence is a well known idea, says Levit:

We have all heard about this, like when you get resistant to one thing you may keep immune for years or in your entire life. You may have immunological reminiscence that you just get from viruses that arent similar to the present virus however are comparable.

Prior an infection with SARS or different coronaviruses just like the widespread chilly could present such prior immunity and immunological reminiscence, says Levit.8 Your T cell system could act to clear your physique of the an infection attributable to comparable however not similar viruses. Notably, he says, this may occur with out producing a number of antibodies.

Furthermore, says Levit, COVID-19 antibody checks solely check for a small fraction of the potential antibodies in opposition to COVID.

One of the wonderful immune system elements depicted in The Wonderful Immunology of our Viral Difficulty are T cells. Their instinct and flexibility in combating invading viruses is simply wanting miraculous. In keeping with Levit there are:9

many a whole lot of hundreds or tens of millions of various kinds of T cells and the distinction between one T cell and one other is that every one is focused to acknowledge a selected peptide fragment held in an MHC [major histocompatibility complex] molecule.

The one ones which might be in your life while youre now not properly, the one ones which might be in your circulation throughout regular life are ones that concentrate on non-self proteins.

All of the T cells that concentrate on self proteins get eradicated in your thymus while youre very younger so that you solely have T cells circulating in your physique that concentrate on MHC that is holding non-self peptides.[This kind of T cell] is a selected variant of a T cell that solely acknowledges this one explicit non-self peptide it acknowledges stuff you have by no means seen earlier than like SARS-CoV-2.

B cells, lymphocytes not processed by the thymus gland, T cells and MHC (main histocompatibility advanced) genes that encode main antigens may mount immunological responses, says Levit.10

That is mainly that when you have by no means seen the virus earlier than and also you mount an immune response that begins with T cells and MHC you may clear the an infection out of your physique utilizing quite a lot of totally different mechanisms Its not essentially the case that it will activate a system that produces the antibodies that the antibody check checks for

Your an infection could get cleared in precept by one of many T cell mediated pathways like cytotoxic T cells that are not examined for by the antibody check.

Individuals who have efficiently fought COVID-19 this manner are contributing to herd immunity within the society however with out triggering the check, Cummins summarizes. Those that are examined for COVID-19 antibodies however obtain a false adverse outcome after they truly harbor the coronavirus antibodies additionally contribute to herd immunity. Its not clear how typically this occurs, the boys agree.

A virus agenda is to duplicate itself in a numbers cells. Not like micro organism, a virus cant reproduce by itself. However, says Levit, if a thousand viruses get into your physique from somebodys sneeze and they do not get into your cells to breed, they do no hurt. Theres only a thousand floating round and so they go nowhere.11

The various proteins that the virus wants to duplicate and infect different cells are buried contained in the virus the place antibodies wont ever see it, so they wont set off a response when the virus is freely floating round on this method, says Levit.

However, and its a massive however, viruses are cagey and use spike proteins to invade a numbers cells, factors out Levig.12

The virus subverts your cell after which ultimately the cell begins budding viruses out from its personal membranes after which ultimately the cell can grow to be virtually like a virus crystal. It may be so taken over with viruses that it simply stops functioning The viruses have even perhaps contaminated the nucleus [of the cell] so the cells a goner.

Ideally, the physiques immune system wont let the virus enter, says Levit.13

One factor your physique can do if it has the fitting antibodies to eliminate viruses is that it could possibly simply utterly encompass the virus. It may trigger it to cease working as a result of there is no extra uncovered spike protein to make use of to sneak right into a cell.

Additionally, as soon as the virus is surrounded by antibodies, different elements of the immune system know that in the event that they see one thing surrounded by antibodies, that factor needs to be digested and eliminated the virus itself as a ball or sphere has bought identifiable proteins. When youve got reminiscence and youve got constructed antibodies it may be attacked immediately as an entity as a virus.

On the conclusion of this glorious video, you mayt assist however be amazed on the intelligence of your immune system in mobilizing defenses in opposition to viruses like COVID-19 in addition to different pathogens.

The refined methods by which your immune system acknowledges invading viruses additionally counsel that herd immunity in opposition to COVID-19 could also be a lot larger than that estimated by public well being officers. As Levit summarizes on the finish of the video:14

it seems that there could very properly be a set of people that have been contaminated with COVID however who arent producing antibodies, maybe as a result of these different immunological mechanisms, T cells or [the] innate system or each cleared them successfully earlier than they began producing a variety of antibodies.

Additionally, conversely, weve got this different phenomenon {that a} bunch of people thatve by no means been contaminated with COVID already seem to have among the immunological equipment thats partially specialised to coping with COVID as a result of they have been contaminated with homologous viruses prior to now.

One conclusion that may be drawn from the video is that antibody checks as a foundation for projected herd immunity are clearly not efficient. Those that could have been contaminated dont essentially harbor antibodies, together with asymptomatic individuals whose sicknesses werent detectable.15

On the videos shut, Cummins expresses awe on the many-faceted human immune system designed to maintain you wholesome and promote herd immunity.

I might assume that [it is] essentially the most unique immunological equipment within the universe this entire system you described that is not the antibody system, however the entire T cell system [that] has been developed and I might guess it is fairly rattling efficient after one million years of evolution.

See the original post here:
The whole lot You Needed to Know About Your Immune System - Editorials 360

Trending: Antibody Purification Services Market Study for 2020 to 2026 Providing Information on Key Players, Growth Drivers and Industry Challenges -…

LOS ANGELES, United States: QY Research has recently published a report, titled Global Antibody Purification Services Market Size, Status and Forecast 2020-2026.The market research report is a brilliant, complete, and much-needed resource for companies, stakeholders, and investors interested in the global Antibody Purification Services market. It informs readers about key trends and opportunities in the global Antibody Purification Services market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive landscape, regional growth, and price. On the whole, it comes out as an intelligent resource that companies can use to gain a competitive advantage in the global Antibody Purification Services market.

Key companies operating in the global Antibody Purification Services market include , Thermo Fisher, Detai Bio-Tech Co, Cusabio, Genscript, KMD Bioscience, SouthernBiotech, Pacific Immunology, COVALAB, Envigo, GE Healthcare, Rockland, Creative Biolabs, Abcam, BBI Solutions, Karebay Bio, HuaBio, Antibodies Inc, Davids Biotechnologie GmbH, ProSci Inc, Bio-Rad Antibody Purification Services

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/customize-request/form/1596443/global-antibody-purification-services-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Antibody Purification Services market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Antibody Purification Services Market Segment By Type:

, Physicochemical Fractionation, Class-specific Affinity, Antigen-specific Affinity Antibody Purification Services

Global Antibody Purification Services Market Segment By Application:

, Monoclonal Antibodies, Polyclonal Antibodies

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Antibody Purification Services market.

Key companies operating in the global Antibody Purification Services market include , Thermo Fisher, Detai Bio-Tech Co, Cusabio, Genscript, KMD Bioscience, SouthernBiotech, Pacific Immunology, COVALAB, Envigo, GE Healthcare, Rockland, Creative Biolabs, Abcam, BBI Solutions, Karebay Bio, HuaBio, Antibodies Inc, Davids Biotechnologie GmbH, ProSci Inc, Bio-Rad Antibody Purification Services

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1596443/global-antibody-purification-services-market

TOC

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered: Ranking by Antibody Purification Services Revenue1.4 Market Analysis by Type1.4.1 Global Antibody Purification Services Market Size Growth Rate by Type: 2020 VS 20261.4.2 Physicochemical Fractionation1.4.3 Class-specific Affinity1.4.4 Antigen-specific Affinity1.5 Market by Application1.5.1 Global Antibody Purification Services Market Share by Application: 2020 VS 20261.5.2 Monoclonal Antibodies1.5.3 Polyclonal Antibodies1.6 Study Objectives1.7 Years Considered 2 Global Growth Trends by Regions2.1 Antibody Purification Services Market Perspective (2015-2026)2.2 Antibody Purification Services Growth Trends by Regions2.2.1 Antibody Purification Services Market Size by Regions: 2015 VS 2020 VS 20262.2.2 Antibody Purification Services Historic Market Share by Regions (2015-2020)2.2.3 Antibody Purification Services Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy2.3.1 Market Top Trends2.3.2 Market Drivers2.3.3 Market Challenges2.3.4 Porters Five Forces Analysis2.3.5 Antibody Purification Services Market Growth Strategy2.3.6 Primary Interviews with Key Antibody Purification Services Players (Opinion Leaders) 3 Competition Landscape by Key Players3.1 Global Top Antibody Purification Services Players by Market Size3.1.1 Global Top Antibody Purification Services Players by Revenue (2015-2020)3.1.2 Global Antibody Purification Services Revenue Market Share by Players (2015-2020)3.1.3 Global Antibody Purification Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global Antibody Purification Services Market Concentration Ratio3.2.1 Global Antibody Purification Services Market Concentration Ratio (CR5 and HHI)3.2.2 Global Top 10 and Top 5 Companies by Antibody Purification Services Revenue in 20193.3 Antibody Purification Services Key Players Head office and Area Served3.4 Key Players Antibody Purification Services Product Solution and Service3.5 Date of Enter into Antibody Purification Services Market3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)4.1 Global Antibody Purification Services Historic Market Size by Type (2015-2020)4.2 Global Antibody Purification Services Forecasted Market Size by Type (2021-2026) 5 Antibody Purification Services Breakdown Data by Application (2015-2026)5.1 Global Antibody Purification Services Market Size by Application (2015-2020)5.2 Global Antibody Purification Services Forecasted Market Size by Application (2021-2026) 6 North America6.1 North America Antibody Purification Services Market Size (2015-2020)6.2 Antibody Purification Services Key Players in North America (2019-2020)6.3 North America Antibody Purification Services Market Size by Type (2015-2020)6.4 North America Antibody Purification Services Market Size by Application (2015-2020) 7 Europe7.1 Europe Antibody Purification Services Market Size (2015-2020)7.2 Antibody Purification Services Key Players in Europe (2019-2020)7.3 Europe Antibody Purification Services Market Size by Type (2015-2020)7.4 Europe Antibody Purification Services Market Size by Application (2015-2020) 8 China8.1 China Antibody Purification Services Market Size (2015-2020)8.2 Antibody Purification Services Key Players in China (2019-2020)8.3 China Antibody Purification Services Market Size by Type (2015-2020)8.4 China Antibody Purification Services Market Size by Application (2015-2020) 9 Japan9.1 Japan Antibody Purification Services Market Size (2015-2020)9.2 Antibody Purification Services Key Players in Japan (2019-2020)9.3 Japan Antibody Purification Services Market Size by Type (2015-2020)9.4 Japan Antibody Purification Services Market Size by Application (2015-2020) 10 Southeast Asia10.1 Southeast Asia Antibody Purification Services Market Size (2015-2020)10.2 Antibody Purification Services Key Players in Southeast Asia (2019-2020)10.3 Southeast Asia Antibody Purification Services Market Size by Type (2015-2020)10.4 Southeast Asia Antibody Purification Services Market Size by Application (2015-2020) 11 India11.1 India Antibody Purification Services Market Size (2015-2020)11.2 Antibody Purification Services Key Players in India (2019-2020)11.3 India Antibody Purification Services Market Size by Type (2015-2020)11.4 India Antibody Purification Services Market Size by Application (2015-2020) 12 Central & South America12.1 Central & South America Antibody Purification Services Market Size (2015-2020)12.2 Antibody Purification Services Key Players in Central & South America (2019-2020)12.3 Central & South America Antibody Purification Services Market Size by Type (2015-2020)12.4 Central & South America Antibody Purification Services Market Size by Application (2015-2020) 13 Key Players Profiles13.1 Thermo Fisher13.1.1 Thermo Fisher Company Details13.1.2 Thermo Fisher Business Overview and Its Total Revenue13.1.3 Thermo Fisher Antibody Purification Services Introduction13.1.4 Thermo Fisher Revenue in Antibody Purification Services Business (2015-2020))13.1.5 Thermo Fisher Recent Development13.2 Detai Bio-Tech Co13.2.1 Detai Bio-Tech Co Company Details13.2.2 Detai Bio-Tech Co Business Overview and Its Total Revenue13.2.3 Detai Bio-Tech Co Antibody Purification Services Introduction13.2.4 Detai Bio-Tech Co Revenue in Antibody Purification Services Business (2015-2020)13.2.5 Detai Bio-Tech Co Recent Development13.3 Cusabio13.3.1 Cusabio Company Details13.3.2 Cusabio Business Overview and Its Total Revenue13.3.3 Cusabio Antibody Purification Services Introduction13.3.4 Cusabio Revenue in Antibody Purification Services Business (2015-2020)13.3.5 Cusabio Recent Development13.4 Genscript13.4.1 Genscript Company Details13.4.2 Genscript Business Overview and Its Total Revenue13.4.3 Genscript Antibody Purification Services Introduction13.4.4 Genscript Revenue in Antibody Purification Services Business (2015-2020)13.4.5 Genscript Recent Development13.5 KMD Bioscience13.5.1 KMD Bioscience Company Details13.5.2 KMD Bioscience Business Overview and Its Total Revenue13.5.3 KMD Bioscience Antibody Purification Services Introduction13.5.4 KMD Bioscience Revenue in Antibody Purification Services Business (2015-2020)13.5.5 KMD Bioscience Recent Development13.6 SouthernBiotech13.6.1 SouthernBiotech Company Details13.6.2 SouthernBiotech Business Overview and Its Total Revenue13.6.3 SouthernBiotech Antibody Purification Services Introduction13.6.4 SouthernBiotech Revenue in Antibody Purification Services Business (2015-2020)13.6.5 SouthernBiotech Recent Development13.7 Pacific Immunology13.7.1 Pacific Immunology Company Details13.7.2 Pacific Immunology Business Overview and Its Total Revenue13.7.3 Pacific Immunology Antibody Purification Services Introduction13.7.4 Pacific Immunology Revenue in Antibody Purification Services Business (2015-2020)13.7.5 Pacific Immunology Recent Development13.8 COVALAB13.8.1 COVALAB Company Details13.8.2 COVALAB Business Overview and Its Total Revenue13.8.3 COVALAB Antibody Purification Services Introduction13.8.4 COVALAB Revenue in Antibody Purification Services Business (2015-2020)13.8.5 COVALAB Recent Development13.9 Envigo13.9.1 Envigo Company Details13.9.2 Envigo Business Overview and Its Total Revenue13.9.3 Envigo Antibody Purification Services Introduction13.9.4 Envigo Revenue in Antibody Purification Services Business (2015-2020)13.9.5 Envigo Recent Development13.10 GE Healthcare13.10.1 GE Healthcare Company Details13.10.2 GE Healthcare Business Overview and Its Total Revenue13.10.3 GE Healthcare Antibody Purification Services Introduction13.10.4 GE Healthcare Revenue in Antibody Purification Services Business (2015-2020)13.10.5 GE Healthcare Recent Development13.11 Rockland10.11.1 Rockland Company Details10.11.2 Rockland Business Overview and Its Total Revenue10.11.3 Rockland Antibody Purification Services Introduction10.11.4 Rockland Revenue in Antibody Purification Services Business (2015-2020)10.11.5 Rockland Recent Development13.12 Creative Biolabs10.12.1 Creative Biolabs Company Details10.12.2 Creative Biolabs Business Overview and Its Total Revenue10.12.3 Creative Biolabs Antibody Purification Services Introduction10.12.4 Creative Biolabs Revenue in Antibody Purification Services Business (2015-2020)10.12.5 Creative Biolabs Recent Development13.13 Abcam10.13.1 Abcam Company Details10.13.2 Abcam Business Overview and Its Total Revenue10.13.3 Abcam Antibody Purification Services Introduction10.13.4 Abcam Revenue in Antibody Purification Services Business (2015-2020)10.13.5 Abcam Recent Development13.14 BBI Solutions10.14.1 BBI Solutions Company Details10.14.2 BBI Solutions Business Overview and Its Total Revenue10.14.3 BBI Solutions Antibody Purification Services Introduction10.14.4 BBI Solutions Revenue in Antibody Purification Services Business (2015-2020)10.14.5 BBI Solutions Recent Development13.15 Karebay Bio10.15.1 Karebay Bio Company Details10.15.2 Karebay Bio Business Overview and Its Total Revenue10.15.3 Karebay Bio Antibody Purification Services Introduction10.15.4 Karebay Bio Revenue in Antibody Purification Services Business (2015-2020)10.15.5 Karebay Bio Recent Development13.16 HuaBio10.16.1 HuaBio Company Details10.16.2 HuaBio Business Overview and Its Total Revenue10.16.3 HuaBio Antibody Purification Services Introduction10.16.4 HuaBio Revenue in Antibody Purification Services Business (2015-2020)10.16.5 HuaBio Recent Development13.17 Antibodies Inc10.17.1 Antibodies Inc Company Details10.17.2 Antibodies Inc Business Overview and Its Total Revenue10.17.3 Antibodies Inc Antibody Purification Services Introduction10.17.4 Antibodies Inc Revenue in Antibody Purification Services Business (2015-2020)10.17.5 Antibodies Inc Recent Development13.18 Davids Biotechnologie GmbH10.18.1 Davids Biotechnologie GmbH Company Details10.18.2 Davids Biotechnologie GmbH Business Overview and Its Total Revenue10.18.3 Davids Biotechnologie GmbH Antibody Purification Services Introduction10.18.4 Davids Biotechnologie GmbH Revenue in Antibody Purification Services Business (2015-2020)10.18.5 Davids Biotechnologie GmbH Recent Development13.19 ProSci Inc10.19.1 ProSci Inc Company Details10.19.2 ProSci Inc Business Overview and Its Total Revenue10.19.3 ProSci Inc Antibody Purification Services Introduction10.19.4 ProSci Inc Revenue in Antibody Purification Services Business (2015-2020)10.19.5 ProSci Inc Recent Development13.20 Bio-Rad10.20.1 Bio-Rad Company Details10.20.2 Bio-Rad Business Overview and Its Total Revenue10.20.3 Bio-Rad Antibody Purification Services Introduction10.20.4 Bio-Rad Revenue in Antibody Purification Services Business (2015-2020)10.20.5 Bio-Rad Recent Development 14 Analysts Viewpoints/Conclusions 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Disclaimer15.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

More:
Trending: Antibody Purification Services Market Study for 2020 to 2026 Providing Information on Key Players, Growth Drivers and Industry Challenges -...

Allogene Therapeutics Announces Publication Highlighting Potential for ALLO-819 In Acute Myeloid Leukemia – BioSpace

SOUTH SAN FRANCISCO, Calif., June 22, 2020 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) therapies for cancer, today announced a publication in Molecular Therapy demonstrating the potential for ALLO-819, an investigational AlloCAR T therapy targeting FLT3 as a novel treatment for acute myeloid leukemia (AML). These preclinical findings were previously presented as a poster at the 61st American Society of Hematology (ASH) Annual Meeting & Exposition in December 2019.

While weve seen exceptional clinical efficacy with autologous CAR T therapies in hematological malignancies, the inherent limitations of autologous cell therapies can be more pronounced in a rapidly progressing disease such as advanced AML, said Barbra Sasu, Ph.D., Chief Scientific Officer at Allogene. The high anti-leukemic activity of ALLO-819 seen in preclinical studies, combined with a safety mechanism to mitigate potential off-tumor effects and the benefits of an off-the-shelf option, supports our goal to advance ALLO-819 for a patient population with very few treatment options.

In this study, healthy donor T lymphocytes were engineered to express CARs that bound to different domains of the FLT3 protein. These CARs were then tested for their ability to mediate specific killing of FLT3-expressing cells without off-target activity. A CAR construct was selected based on exhibiting minimal potential for exhaustion and potent antitumor activity in vitro and in vivo models.The lead candidate was then engineered to contain an off-switch responsive to rituximab, resulting in ALLO-819.

ALLO-819 utilizes Cellectis technologies. Allogene holds global development and commercial rights for this investigational candidate. This pre-clinical research was conducted in collaboration with both Cellectis and Pfizer Cancer Immunology Discovery.

About Acute Myeloid LeukemiaAcute myeloid leukemia (AML) is a form of cancer that is characterized by infiltration of the bone marrow, blood, and other tissues by proliferative, clonal, abnormally differentiated, and occasionally poorly differentiated cells of the hematopoietic system.i AML is the second most common type of leukemia diagnosed in adults and children, but most cases occur in adults, making up 32% of all adult leukemia cases.ii Patients with relapsed or refractory AML often have a poor prognosis and limited treatment options, and is typically only curable in 5 to 15% of patients who are older than 60 years of age.iii

About Allogene TherapeuticsAllogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) therapies for cancer. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of off-the-shelf CAR T cell therapy candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients. For more information, please visit http://www.allogene.com, and follow @AllogeneTx on Twitter and LinkedIn.

Cautionary Note on Forward-Looking Statements This press release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The press release may, in some cases, use terms such as "predicts," "believes," "potential," "proposed," "continue," "estimates," "anticipates," "expects," "plans," "intends," "may," "could," "might," "will," "should" or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Forward-looking statements include statements regarding intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: the ability to further research and develop ALLO-819 for the treatment of AML, the potential benefits of ALLO-819, the ability to manufacture ALLO-819, the ability to develop allogeneic CAR T therapies for cancer and the potential benefits of AlloCAR T therapy. Various factors may cause differences between Allogenes expectations and actual results as discussed in greater detail in Allogenes filings with the SEC, including without limitation in its Form 10-Q for the quarter ended March 31, 2020. Any forward-looking statements that are made in this press release speak only as of the date of this press release. Allogene assumes no obligation to update the forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.

AlloCAR T is a trademark of Allogene Therapeutics, Inc.

Allogene Media/Investor Contact:Christine CassianoChief Communications Officer(714) 552-0326Christine.Cassiano@allogene.com

_____________________

i Dhner H, Weisdorf D, Bloomfield C. Acute Myeloid Leukemia. N Engl J Med. 2015; 373:1136-1152.ii Leukemia - Acute Myeloid - AML: Statistics. Retrieved from https://www.cancer.net/cancer-types/leukemia-acute-myeloid-aml/statistics.iii Dhner H, Estey E, Amadori S, et al. Blood. 2010; 115 (3): 453474.

Follow this link:
Allogene Therapeutics Announces Publication Highlighting Potential for ALLO-819 In Acute Myeloid Leukemia - BioSpace